- Home
- Equipment
- switzerland
- disease patients
Show results for
Refine by
Disease Patients Equipment Supplied In Switzerland
8 equipment items found
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Krabbe disease is a severe neurodegenerative disorder caused by mutations in GALC, the gene that encodes the galactosylceramidase (GALC) enzyme. These mutations cause GALC misfolding and dysfunction, which leads to the toxic buildup up fats in the central nervous system (CNS) and ultimately leads to the demyelination and death of neurons. There is no cure for this ...
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Clinical and research-grade leukopaks - mobilized or non-mobilized from healthy and diseased subjects, including oncology donors. ...
Manufactured by:AB2 Bio Ltd. based inLausanne, SWITZERLAND
Macrophage Activation Syndrome. Macrophage Activation Sysdrome (MAS) is a very severe complication of rheumatic diseases. Mortality ranges between 10-30% for patients with MAS and there is no registered therapy. MAS occurs frequently in systemic Juvenile Idiopathic Arthritis (soJIA) and in Adult onset Still’s Disease (AOSD) ...
Manufactured by:BioLingus AG based inHergiswil, SWITZERLAND
The Cytokine Stabilisation and Slow Release (CSSR) technology is the "mother" of the BioLingus ...
Manufactured by:Infomed SA based inMeinier, SWITZERLAND
Like TPE, cascade filtration and DFPP allow to remove the larger substances from the blood, such as antibodies, fibrinogen or LDL-cholesterol. Its interest remains in the fact that the plasma is filtered and then returned to the patient, avoiding or minimizing the need for replacement fluids. Thus, cascade filtration/DFPP applies to both acute and chronic ...
Manufactured by:Applied Pharma Research s.a. based inBalerna, SWITZERLAND
APR TD012 is a clinical stage drug candidate for the treatment of wounds in Hailey Hailey Disease (HHD) patients. The product improves healing process thanks to its bioburden control and its anti-oxidant properties.Oxidative stress has been demonstrated to play a specific role in the pathogenesis of HHD by regulating the expression of factors playing an ...
by:F. Hoffmann-La Roche Ltd. based inBasel, SWITZERLAND
Alecensa is a highly selective, central nervous system-active, oral medicine used for the treatment of people with non-small cell lung cancer (NSCLC) whose tumours are identified as anaplastic lymphoma kinase (ALK)-positive. Alecensa is a tyrosine kinase inhibitor that targets ALK fusion proteins, preventing signalling within cancer cells to inhibit their growth and ...
Manufactured by:EsoCap AG based inBasel, SWITZERLAND
EsoCap owns a unique drug delivery platform allowing the topical application of drug substances for targeted and long-lasting treatment of diseases of the upper gastrointestinal tract for the first ...